Pharvaris Insider Schoodic Management BV Files to Sell 300,000 Shares Worth $10.5M
PHVS sits 84% above its 52-week low of $20.65.
Summary
Pharvaris insider Schoodic Management BV filed to sell 300,000 shares worth about $10.5 million, the largest single insider sale filing in the recent 90-day distribution pattern.
Key Events · Ownership and Investor Activity · PHVS
-
Largest Insider Sale Filing
Schoodic Management BV, an officer/director entity, filed to sell 300,000 shares worth approximately $10.5 million, the largest single Form 144 in the recent 90-day insider distribution pattern.
-
Founder Stock Disposition
The shares are founder stock acquired on 2015-11-26, not a recent option exercise, indicating a long-held position being monetized.
-
Ongoing Distribution Pattern
This is the 22nd Form 144 filing in 90 days, with $11.2 million in net insider sales and no open-market buys, continuing a consistent insider distribution trend.
-
Immediate Sale Date
The proposed sale date is 2026-09-17, the same day as the filing, suggesting the sale may occur promptly.
Analysis · PHVS · Life Sciences
Schoodic Management BV, an officer/director entity, filed to sell 300,000 shares worth approximately $10.5 million. This is the largest single Form 144 in the recent 90-day distribution pattern, which has seen 22 filings and $11.2 million in net insider sales with no open-market buys. The sale is proposed for 2026-09-17, the same day as the filing, and the shares are founder stock acquired in 2015, not a recent option exercise.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.9% of the 1656 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PHVS was trading at $37.96 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $20.65 to $43.25. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.